Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 31,741.0 | $683K | 0.19% | NEW | — | $21.52 | -22.5% |
| 182 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 1,717.0 | $683K | 0.19% | NEW | — | $397.65 | -25.7% |
| 183 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 25,060.0 | $682K | 0.18% | NEW | — | $27.22 | +4.1% |
| 184 | LGND | LIGAND PHARMACEUTICALS INC | Healthcare | 3,605.0 | $682K | 0.18% | NEW | — | $189.07 | +24.5% |
| 185 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 27,086.0 | $680K | 0.18% | NEW | — | $25.12 | +63.3% |
| 186 | ZLAB | ZAI LAB LTD | Healthcare | 38,457.0 | $678K | 0.18% | NEW | — | $17.64 | +5.5% |
| 187 | — | KINIKSA PHARMACEUTICALS INTL | — | 16,432.0 | $678K | 0.18% | NEW | — | $41.25 | — |
| 188 | JFR | NUVEEN FLOATING RATE INCOME | Financial Services | 86,463.0 | $677K | 0.18% | NEW | — | $7.83 | -3.1% |
| 189 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 1,382.0 | $673K | 0.18% | NEW | — | $487.25 | +18.7% |
| 190 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 25,170.0 | $672K | 0.18% | NEW | — | $26.71 | -20.4% |
| 191 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 30,922.0 | $671K | 0.18% | NEW | — | $21.70 | +36.7% |
| 192 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 8,454.0 | $669K | 0.18% | NEW | — | $79.11 | -3.8% |
| 193 | — | NUVEEN CR STRATEGIES INCOME | — | 132,878.0 | $667K | 0.18% | NEW | — | $5.02 | — |
| 194 | LEGN | LEGEND BIOTECH CORP | Healthcare | 30,617.0 | $666K | 0.18% | NEW | — | $21.74 | +35.8% |
| 195 | FCT | FIRST TR SR FLTG RATE INCOME | Financial Services | 65,895.0 | $664K | 0.18% | NEW | — | $10.07 | -3.7% |
| 196 | GERN | GERON CORP | Healthcare | 502,509.0 | $663K | 0.18% | NEW | — | $1.32 | -3.0% |
| 197 | BCSF | BAIN CAP SPECIALTY FIN INC | Financial Services | 47,637.0 | $663K | 0.18% | NEW | — | $13.91 | -4.0% |
| 198 | — | ASCENDIS PHARMA A/S | — | 3,100.0 | $661K | 0.18% | NEW | — | $213.24 | — |
| 199 | BBDC | BARINGS BDC INC | Financial Services | 71,617.0 | $657K | 0.18% | NEW | — | $9.18 | -6.3% |
| 200 | ESPR | ESPERION THERAPEUTICS INC NE | Healthcare | 177,508.0 | $657K | 0.18% | NEW | — | $3.70 | -15.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
25.9%
Financial Services
25.7%
Technology
17.4%
Industrials
10.0%
Consumer Cyclical
7.5%
Communication Services
4.3%
Energy
2.6%
Real Estate
2.5%
Consumer Defensive
1.8%
Basic Materials
1.5%